Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
Find all 2018 ESMO Guidelines
and
discover the ESMO Guidelines Slide Sets
!
Melanoma Adjuvant Setting - State of the Art , by Riccardo Marconcini
19 Dec 2018
Analysis of a cohort of 67 patients sheds light on the clinical course of EGFR-mutated lung cancers that transform to or present as small-cell lung...
18 Dec 2018
Immediate surgery may not be the best option for patients with metastatic renal cell carcinoma
17 Dec 2018
Ixazomib maintenance therapy improves progression-free survival after autologous stem cell transplantation for multiple myeloma
14 Dec 2018
Over 23 years, patients who undergo radical surgery for localised prostate cancer may achieve an average 2.9 years longer survival than those who...
13 Dec 2018
Women undergoing whole- or partial-breast radiotherapy after breast conserving surgery can expect a reduction in moderate/marked adverse events over...
Reporting from ASH 2018, Umberto Vitolo first discusses the results from the FLYER trial that explored de-escalation of standard treatment in young, low risk DLBCL patients. He also comments on results from everyday clinical practice in the US about CAR-T cell therapy, which are very similar with what has been observed in the clinical trials setting.
13-16 Dec 2018, Geneva, Switzerland
23-25 Nov 2018, Singapore, Singapore
23-24 Nov 2018, Zurich, Switzerland
16-17 Nov 2018, Lugano, Switzerland
08-11 Nov 2018, Amsterdam, Netherlands
02-03 Nov 2018, Zurich, Switzerland
19-23 Oct 2018, Munich, Germany
04-05 Oct 2018, Lugano, Switzerland
28-29 Sep 2018, Valencia, Spain
28-29 Sep 2018, Athens, Greece
21-22 Sep 2018, Singapore
19-20 Sep 2018, Singapore, Singapore
14-15 Sep 2018, Paris, France
01-03 Sep 2018, Oxford, United Kingdom
20-23 Jun 2018, Barcelona, Spain
